
Loading, please wait...

Loading, please wait...

Management of complex proximal humerus fractures in older adults remains controversial because bone quality, tuberosity involvement and rotator-cuff function all influence the result. In this prospective randomized trial, adults aged 80 years or older with displaced three- or four-part proximal humeral fractures were assigned to reverse shoulder arthroplasty or nonoperative treatment. The study directly addressed a clinically important question: whether replacing the joint can provide better pain relief and function than accepting fracture healing without surgery. The trial supports reverse arthroplasty as a reasonable option for carefully selected very elderly patients, particularly when fracture complexity and cuff dysfunction make fixation or reliable tuberosity healing difficult. At the same time, treatment should not be reduced to age alone. Surgical risk, pre-injury function, frailty, expectations and the feasibility of rehabilitation remain central to decision-making. The study is useful because it places reverse arthroplasty within a comparative framework rather than relying only on case series. For an orthopaedic surgeon, the practical takeaway is to consider reverse arthroplasty when the fracture pattern is unlikely to deliver predictable function with conservative care, while still individualising the decision according to patient biology and goals.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Management of complex proximal humerus fractures in older adults remains controversial because bone quality, tuberosity involvement and rotator-cuff function all influence the result. In this prospective randomized trial, adults aged 80 years or older with displaced three- or four-part proximal humeral fractures were assigned to reverse shoulder arthroplasty or nonoperative treatment. The study directly addressed a clinically important question: whether replacing the joint can provide better pain relief and function than accepting fracture healing without surgery. The trial supports reverse arthroplasty as a reasonable option for carefully selected very elderly patients, particularly when fracture complexity and cuff dysfunction make fixation or reliable tuberosity healing difficult. At the same time, treatment should not be reduced to age alone. Surgical risk, pre-injury function, frailty, expectations and the feasibility of rehabilitation remain central to decision-making. The study is useful because it places reverse arthroplasty within a comparative framework rather than relying only on case series. For an orthopaedic surgeon, the practical takeaway is to consider reverse arthroplasty when the fracture pattern is unlikely to deliver predictable function with conservative care, while still individualising the decision according to patient biology and goals.
3 weeks back

Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back

A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month

Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back